Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marienke A A M de Bruijn

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Handbook of Clinical Neurology|April 27, 2016
Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathiesMarienke A A M De Bruijn, Maarten J Titulaer
Cerebrovascular Diseases (Basel, Switzerland)|June 28, 2014
Long-term cognitive outcome of ischaemic stroke in young adultsMarienke A A M de Bruijn, Nathalie E Synhaeve, Mariëlle W A van Rijsbergen, et al.
Nature Reviews. Disease Primers|September 11, 2025
Autoimmune encephalitisMarienke A A M de Bruijn, Frank Leypoldt, Josep Dalmau, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 29, 2015
Quality of Life after Young Ischemic Stroke of Mild Severity Is Mainly Influenced by Psychological FactorsMarienke A A M de Bruijn, Nathalie E Synhaeve, Mariëlle W A van Rijsbergen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 24, 2018
Predictive value of electroencephalography in anti-NMDA receptor encephalitisAgnes van Sonderen, Samuel Arends, Dénes L J Tavy, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2020
Pediatric autoimmune encephalitis: Recognition and diagnosisMarienke A A M de Bruijn, Arlette L Bruijstens, Anna E M Bastiaansen, et al.
Neuro-Oncology Advances|October 25, 2021
Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromesAnna E M Bastiaansen, Adriaan H C de Jongste, Marienke A A M de Bruijn, et al.
Neurology|September 4, 2016
Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-upAgnes van Sonderen, Roland D Thijs, Elias C Coenders, et al.
Neurology|April 3, 2016
The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodiesAgnes van Sonderen, Marco W J Schreurs, Marienke A A M de Bruijn, et al.
Neurology|April 29, 2018
Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitisMarienke A A M de Bruijn, Femke K Aarsen, Marielle P van Oosterhout, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Handbook of Clinical Neurology|April 27, 2016
Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathiesMarienke A A M De Bruijn, Maarten J Titulaer
Cerebrovascular Diseases (Basel, Switzerland)|June 28, 2014
Long-term cognitive outcome of ischaemic stroke in young adultsMarienke A A M de Bruijn, Nathalie E Synhaeve, Mariëlle W A van Rijsbergen, et al.
Nature Reviews. Disease Primers|September 11, 2025
Autoimmune encephalitisMarienke A A M de Bruijn, Frank Leypoldt, Josep Dalmau, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 29, 2015
Quality of Life after Young Ischemic Stroke of Mild Severity Is Mainly Influenced by Psychological FactorsMarienke A A M de Bruijn, Nathalie E Synhaeve, Mariëlle W A van Rijsbergen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 24, 2018
Predictive value of electroencephalography in anti-NMDA receptor encephalitisAgnes van Sonderen, Samuel Arends, Dénes L J Tavy, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2020
Pediatric autoimmune encephalitis: Recognition and diagnosisMarienke A A M de Bruijn, Arlette L Bruijstens, Anna E M Bastiaansen, et al.
Neuro-Oncology Advances|October 25, 2021
Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromesAnna E M Bastiaansen, Adriaan H C de Jongste, Marienke A A M de Bruijn, et al.
Neurology|September 4, 2016
Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-upAgnes van Sonderen, Roland D Thijs, Elias C Coenders, et al.
Neurology|April 3, 2016
The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodiesAgnes van Sonderen, Marco W J Schreurs, Marienke A A M de Bruijn, et al.
Neurology|April 29, 2018
Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitisMarienke A A M de Bruijn, Femke K Aarsen, Marielle P van Oosterhout, et al.
Pageof 3